Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Fabienne Le Goc-Sager"'
Autor:
Isabelle Vincent-Cantini, Catherine Barbe, Catherine Delbaldo, Katia Lièvremont, Nathanael Loric, Eléa Duval, Mireille Favier, Vincent Launay, Eric-Alban Giroux, Isabelle Bonnet, Fabienne Le Goc-Sager
Publikováno v:
Bulletin du Cancer. 105:862-872
Resume Introduction De nouvelles formes galeniques de trastuzumab et rituximab ont ete developpees pour administration par voie sous-cutanee, permettant ainsi des protocoles d’administration moins contraignants en hopital de jour. L’objectif de c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b3cef935b01df540ed72d36efe49583
https://doi.org/10.1016/j.bulcan.2018.07.014
https://doi.org/10.1016/j.bulcan.2018.07.014
Autor:
Mireille, Favier, Fabienne, Le Goc-Sager, Isabelle, Vincent-Cantini, Vincent, Launay, Eric-Alban, Giroux, Katia, Lièvremont, Isabelle, Bonnet, Catherine, Barbe, Eléa, Duval, Nathanael, Loric, Catherine, Delbaldo
Publikováno v:
Bulletin du cancer. 105(10)
New pharmaceutical forms of trastuzumab and rituximab which can be administered by the subcutaneous route have been developed recently. For day hospitalisation units, these can be used in simpler treatment protocols than previous intravenous formulat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4378b19619d3708e49a8a90821d43e2c
https://pubmed.ncbi.nlm.nih.gov/30244982
https://pubmed.ncbi.nlm.nih.gov/30244982